These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1154274)

  • 1. Gastrojejunostomy inhibits postshunt siderosis.
    Doberneck RC; Fischer R; Smith D
    Surgery; 1975 Sep; 78(3):334-8. PubMed ID: 1154274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of hemosiderosis and hematopoiesis after end-to-side and side-to-side portacaval shunt.
    Doberneck RC
    Surgery; 1971 Sep; 70(3):428-32. PubMed ID: 5568528
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing siderosis after portacaval shunt and pancreatic duct ligation.
    Doberneck RC
    J Surg Res; 1970 Nov; 10(11):543-9. PubMed ID: 5489512
    [No Abstract]   [Full Text] [Related]  

  • 4. HEPATIC IRON STORAGE AND ERYTHROKINETICS AFTER PORTACAVAL SHUNT.
    DOBERNECK RC; MORSE AS; CONRAD ME; BERMAN AR
    Surgery; 1965 Jun; 57():800-8. PubMed ID: 14297954
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and chronic splanchnic blood flow responses to portacaval shunt in the normal dog.
    Gurll NJ; Reynolds DG; Coon D; Shirazi SS
    Gastroenterology; 1980 Jun; 78(6):1432-6. PubMed ID: 7372063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of postshunt hemochromatosis--parenchymal siderosis in patients with cirrhosis occuring after portasystemic shunt surgery. A review of the literature and report of two additional cases.
    Ecker JA; Gray PA; McKittrick JE; Dickson DR
    Am J Gastroenterol; 1968 Jul; 50(1):13-29. PubMed ID: 5662506
    [No Abstract]   [Full Text] [Related]  

  • 7. An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy.
    Yilmaz S; Kirimlioglu V; Katz D; Basak K; Caglikulekci M; Kayaalp C; Yildirim B; Akoglu M
    Dig Dis Sci; 2002 Sep; 47(9):1943-52. PubMed ID: 12353834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of postshunt liver failure.
    Reichle FA; Rao NS; Reichle RM; Chang KH
    Surgery; 1977 Nov; 82(5):738-49. PubMed ID: 918862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing hemosiderosis. The role of iron absorption.
    Doberneck RC
    Am J Surg; 1971 Jul; 122(1):33-5. PubMed ID: 5091851
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic morphologic changes following end-to-side portacaval shunt in dogs.
    Lanier VC; Buchanan RD; Foster JH
    Am Surg; 1968 Mar; 34(3):185-95. PubMed ID: 5638502
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.
    Rossaro L; Mazzaferro V; Scotti-Foglieni CL; Williams DS; Simplaceanu E; Simplaceanu V; Francavilla A; Starzl TE; Ho C; Van Thiel DH
    Hepatology; 1991 Apr; 13(4):780-5. PubMed ID: 2010174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of portacaval shunt and arterialization of the liver on bile acid metabolism.
    Horak W; Gangl A; Funovics J; Grabner G
    Gastroenterology; 1975 Aug; 69(2):338-41. PubMed ID: 1150042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of hepatic hemosiderin by gross inspection of iron-stained histologic sections.
    Conn HO; Strauss RH; Conn MB
    Yale J Biol Med; 1972 Apr; 45(2):133-8. PubMed ID: 4112011
    [No Abstract]   [Full Text] [Related]  

  • 15. EXPERIMENTAL HEPATIC SIDEROSIS FOLLOWING PORTACAVAL SHUNT.
    RUBIN E; KOHAN P; TOMITA F; JACOBSON JH
    Proc Soc Exp Biol Med; 1964 Feb; 115():350-2. PubMed ID: 14121607
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt.
    Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H
    Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "H-graft" in portacaval shunt in dogs.
    Grga A; Maticić Z; Hlevnjak D; Hofman B
    Mater Med Pol; 1994; 26(3):109-12. PubMed ID: 7603080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decarboxylation to tyramine: an important route of tyrosine metabolism in dogs with experimental hepatic encephalopathy.
    Faraj BA; Ali FM; Ansley JD; Malveaux EJ
    Gastroenterology; 1978 Dec; 75(6):1041-4. PubMed ID: 710855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterialization of the liver in combination with a portacaval shunt in the dog.
    Adamsons RJ; Arif S; Babich A; Butt K; Lam A; Minkowitz S
    Surg Gynecol Obstet; 1975 Apr; 140(4):594-600. PubMed ID: 1129667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.